PHS
MRVL icon

PFM Health Sciences’s Marvell Technology MRVL Stock Holding History

PFM Health Sciences’s Portfolio MRVL Stock Details MRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,205,837
Closed -$19.9M – 101
2017
Q2 		$19.9M Sell
1,205,837
-7,273,785
-86% -$118M 0.54% 57
2017
Q1 		$129M Buy
8,479,622
+6,433,672
+314% +$99.1M 3.24% 1
2016
Q4 		$28.4M Buy
+2,045,950
New +$27.9M 0.8% 46

Other funds holding MRVL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SV
Starboard Value New York $4.52B AUM 19.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CAM
Contour Asset Management New York $4.22B AUM 26.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PFM Health Sciences's MRVL Position: Q3 2017 in Review

PFM Health Sciences sold out of Marvell Technology (MRVL) in Q3 2017, closing a stake of 1,205,837 shares — an estimated $19.9M sold.

PFM Health Sciences first reported a position in MRVL in Q4 2016 and held it in 3 quarters. The position peaked at $129M in Q1 2017. 330 funds tracked by Wall St. Rank hold MRVL as of Q3 2017.

  • PFM Health Sciences reported no remaining Marvell Technology position as of Q3 2017 after selling out during the quarter.
  • PFM Health Sciences sold 1,205,837 Marvell Technology shares in Q3 2017, an estimated $19.9M.
  • PFM Health Sciences first reported a position in Marvell Technology in Q4 2016 and held it in 3 quarters.
  • PFM Health Sciences's Marvell Technology position peaked at $129M in Q1 2017.
  • 330 funds tracked by Wall St. Rank held Marvell Technology as of Q3 2017.

Based on PFM Health Sciences's 13F filing for Q3 2017, filed 14 Nov 2017.